Tue, Jul 22, 2014, 8:54 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Ligand Pharmaceuticals Incorporated Message Board

biozoomie 1 post  |  Last Activity: Apr 24, 2014 2:25 PM Member since: Oct 23, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.
    Scheinberg P1, Singulane CC, Barbosa LS, Scheinberg M.
    Author information

    1Hematology Service, Oncology Center, Hospital São José, Beneficência Portuguesa, São Paulo, Brazil.
    Abstract

    Eltrombopag is a new thrombomimetic medication approved for the treatment of immune thrombocytopenia. There are very few reports on the use of eltrombopag in patients with thrombocytopenia associated with sytemic lupus.We present a recent case of a patient with lupus with severe thrombocytopenia refractory to conventional therapy and full recovery with the use of eltrombopag. The present status of the literature with the use of this medication in patients with lupus is reviewed and discussed.

    Sentiment: Strong Buy

LGND
49.14-2.31(-4.49%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Puma Biotechnology, Inc.
NYSETue, Jul 22, 2014 4:01 PM EDT
Microsoft Corporation
NasdaqGSTue, Jul 22, 2014 4:00 PM EDT